ACHV Biotech
ACHV had good earnings in mid-March and has been in an ascending triangle since that time.
The uptrend had a correction April 17th to 20th to which buyers responded with spiking
buying volume. Current volume is 3x relative to the usual and customary historical volume
averages.
I will take a long trade on this when price descends to the support trendline as notified by
an alert set on Tradingview. The target is the post covid highs of $ 17.00 . This is modest
compared with the average upside of the analysts of $ 22+ ( see the link below)
I will take out a sizeable stock position and also some insurance in the form of a long term
put option to manage the risk on the trade.
The uptrend had a correction April 17th to 20th to which buyers responded with spiking
buying volume. Current volume is 3x relative to the usual and customary historical volume
averages.
I will take a long trade on this when price descends to the support trendline as notified by
an alert set on Tradingview. The target is the post covid highs of $ 17.00 . This is modest
compared with the average upside of the analysts of $ 22+ ( see the link below)
I will take out a sizeable stock position and also some insurance in the form of a long term
put option to manage the risk on the trade.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.